Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace ...

Back in 2024, on May 14, Mad Money’s Jim Cramer was asked about Moderna, Inc. (NASDAQ:MRNA), explaining that some family ...

The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...

The stock might be down substantially over the past three years, but it isn't out of the picture yet. Teladoc Health is a ...

A combination shot for flu and Covid-19 using messenger RNA generated antibodies in a study, but US government regulators ...

Learn more about whether Kymera Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

Moderna’s Chief People & Digital Officer, Tracey Franklin, has become the latest high-profile executive to reveal how agentic ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Moderna researchers reported that the combo shot produced a stronger immune response against COVID-19 and most flu strains ...

Back in 2024, on May 14, Mad Money’s Jim Cramer was asked about Moderna, Inc. (NASDAQ:MRNA), explaining that some family members had owned it during its run-up to $400 and that he was now ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.